Board Meeting Announcement for Mankind Pharma Ltd - May 21, 2025

Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2025 inter alia to consider and approve Pursuant to Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday May 21 2025 inter-alia to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31 2025. Further in continuation of our earlier letter dated March 26 2025 under subject Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading the trading window for trading in the securities of the Company shall remain closed till May 23 2025